These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9877531)

  • 1. Clinical and genetic aspects of progressive supranuclear palsy.
    Litvan I; Hutton M
    J Geriatr Psychiatry Neurol; 1998; 11(2):107-14. PubMed ID: 9877531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence analysis of tau in familial and sporadic progressive supranuclear palsy.
    Morris HR; Katzenschlager R; Janssen JC; Brown JM; Ozansoy M; Quinn N; Revesz T; Rossor MN; Daniel SE; Wood NW; Lees AJ
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):388-90. PubMed ID: 11861703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial aggregation of parkinsonism in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
    Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the understanding of tau protein and movement disorders.
    Arvanitakis Z; Wszolek ZK
    Curr Opin Neurol; 2001 Aug; 14(4):491-7. PubMed ID: 11470966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progressive supranuclear palsy; an unusual form of parkinsonism].
    Donker Kaat L; Boon AJ; Heutink P; van Swieten JC
    Ned Tijdschr Geneeskd; 2004 Mar; 148(11):519-23. PubMed ID: 15054950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
    Kertesz A; Munoz D
    Dement Geriatr Cogn Disord; 2004; 17(4):282-6. PubMed ID: 15178937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive supranuclear palsy--parkinsonian disorder with tau pathology.
    Kowalska A; Jamrozik Z; Kwieciński H
    Folia Neuropathol; 2004; 42(2):119-23. PubMed ID: 15266787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.
    Morris HR; Janssen JC; Bandmann O; Daniel SE; Rossor MN; Lees AJ; Wood NW
    J Neurol Neurosurg Psychiatry; 1999 May; 66(5):665-7. PubMed ID: 10209184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
    Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
    Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
    Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy.
    de Silva R; Weiler M; Morris HR; Martin ER; Wood NW; Lees AJ
    Neurosci Lett; 2001 Oct; 311(3):145-8. PubMed ID: 11578815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further extension of the H1 haplotype associated with progressive supranuclear palsy.
    Pastor P; Ezquerra M; Tolosa E; Muñoz E; Martí MJ; Valldeoriola F; Molinuevo JL; Calopa M; Oliva R
    Mov Disord; 2002 May; 17(3):550-6. PubMed ID: 12112206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP.
    Morris HR; Osaki Y; Holton J; Lees AJ; Wood NW; Revesz T; Quinn N
    Neurology; 2003 Jul; 61(1):102-4. PubMed ID: 12847166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin polymorphisms in progressive supranuclear palsy.
    Ros R; Ampuero I; García de Yébenes J
    J Neurol Sci; 2008 May; 268(1-2):176-8. PubMed ID: 18022644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration.
    Higgins JJ; Litvan I; Nee LE; Loveless JM
    Neurology; 1999 Jan; 52(2):404-6. PubMed ID: 9932968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive supranuclear palsy: a systematic review.
    Rampello L; Buttà V; Raffaele R; Vecchio I; Battaglia G; Cormaci G; Alvano A
    Neurobiol Dis; 2005 Nov; 20(2):179-86. PubMed ID: 16242626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene.
    Higgins JJ; Litvan I; Pho LT; Li W; Nee LE
    Neurology; 1998 Jan; 50(1):270-3. PubMed ID: 9443491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.